KIDNEY TUMORS: MORFOLOGICAL DIAGNOSTICS AND SURVIVAL PROGNOSIS (4-7)

DOI: 10.31618/ESU.2413-9335.2019.1.60.4-6

Дата публикации статьи в журнале: 2019/04/21

Название журнала: Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале, Выпуск: 60, Том: 1, Страницы в выпуске: 4-7

Автор: Maslyakova Galina Nikifirovna
Professor.Doctor of Medical Science, Department of Pathological Anatomy, Saratov

Автор: Medvedeva Anna Valentinovna
Assistant Professor,Ph.D, Department of Pathological Anatomy, Saratov

Автор: Bucharskaya Alla Borisivna
Ph.D, Department of Innovative Development, Institute of Urology and Reproductive Health, Moscow

Анотация: Background. The article aims to present a comparative analysis of literature materials and research data on the epidemiology, morphology and prognosis of disease in patients with renal tumors in Saratov region, Russia. Methods. Analysis was performed on clinical and morphological parameters of 469 patients with kidney tumors who were examined and treated at the Clinical Hospital №3 of “Saratov State Medical University” within a 5-year period (from 2006 to 2010). Results. Age- and gender-related characteristics of benign and malignant tumors of the kidneys, their morphological, immunohistochemical characteristics and relationships with disease prognosis have been established. Conclusions. Early diagnosis, precise morphological characterization and timely, adequate treatment of kidney tumors will improve the quality of life and reduce morbidity and mortality rates.

Ключевые слова: kidney tumors, epidemiology,morphology diagnostics,immunohistochemistry,prognosis,

Данные для цитирования: Maslyakova Galina Nikifirovna Medvedeva Anna Valentinovna Bucharskaya Alla Borisivna . KIDNEY TUMORS: MORFOLOGICAL DIAGNOSTICS AND SURVIVAL PROGNOSIS (4-7) // Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале. Медицинские науки. 2019/04/21; 60(1):4-7. 10.31618/ESU.2413-9335.2019.1.60.4-6

Скачать в формате PDF

Список литературы: 1. Brunelli M, Gobbo S, Cossu-Rocca P et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mol Pathol 2007;20(3): P.303-9. 2. Charlesworth PJ, Kilbey N, Taylor M et al. Automated uro-oncology data collection: the Cancer Research Uro-Oncology Database. BJU Int. 2009;20.[Epub ahead of print]. 3. Eble JN: Pathology and Genetics of Tumors of Urinary System and Male Genital Organs. 4. Gong K, Zhang N, He Z et al. Multilocular cystic renal cell carcinoma: an experience of clinical management for 31 cases. J Cancer Res Clin Oncol. 2008;134: P.433–7. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17846788 5. Han KR, Bui MH, Pantusk AJ et al.: TNM T3A renal cell carcinoma: adrenal gland involvement in not the same as renal fat invasion. J Urol. 2003;169: P.899-903. 6. Helmy T, Sarhan O, Sarhan M et al.: Renal cell carcinoma in children: single-center experience. J Pediatr Surg. 2009;44(12):5-7. In: Sauter G, Epstein JI, Sesterhen EA, editors. World Health Organization Classification of Tumors. Lion; 2004. P.5-76. 7. Jemal A. Cancer statistics. Cancer J Clin. 2002;52:23-47. 8. Patard JJ, Rioux-Leclercq N, Masson D et al. Absence of VHL gene alteration and high VEGF expression are associated with tumor aggressiveness and poor survival of renal-cell carcinoma. Br J Cancer. 2009;101(8): P.1417-24. 9. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer. Cancer J Clin. 2004;54: P.41-52.